Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 9, Issue 4, 2010, Pages 257-262

  Olesen, Hanne Vebert ^a   Holmskov, Uffe ^b   Schiøtz, Peter Oluf ^a   Sørensen, Grith Lykke ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; METHIONINE; SURFACTANT PROTEIN D; THREONINE; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LEUKOCYTE COUNT; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; AGED; BLOOD; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; YOUNG ADULT;

EID: 77953915044     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2010.03.011     Document Type: Article

References (23)

1. van de Wetering J.K., van E.M., van Golde L.M., Hartung T., van Strijp J.A., Batenburg J.J. Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of gram-positive bacteria. J Infect Dis Nov. 1 2001, 184(9):1143-1151.
2. Bufler P., Schmidt B., Schikor D., Bauernfeind A., Crouch E.C., Griese M. Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide. Am J Respir Cell Mol Biol 2003 Feb, 28(2):249-256.
3. Starosta V., Griese M. Oxidative damage to surfactant protein D in pulmonary diseases. Free Radic Res 2006 Apr, 40(4):419-425.
4. Dominguez C., Gartner S., Linan S., Cobos N., Moreno A. Enhanced oxidative damage in cystic fibrosis patients. Biofactors 1998, 8(1-2):149-153.
5. McGrath L.T., Mallon P., Dowey L., Silke B., McClean E., McDonnell M., et al. Oxidative stress during acute respiratory exacerbations in cystic fibrosis. Thorax 1999 Jun, 54(6):518-523.
6. Kogan I., Ramjeesingh M., Li C., Kidd J.F., Wang Y., Leslie E.M., et al. CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J 2003 May 1, 22(9):1981-1989.
7. Sorensen G.L., Husby S., Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 2007, 212(4-5):381-416.
8. Leth-Larsen R., Nordenbaek C., Tornoe I., et al. Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia. Clin Immunol 2003 Jul, 108(1):29-37.
9. Takahashi H., Fujishima T., Koba H., Murakami S., Kurokawa K., Shibuya Y., et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 2000 Sep, 162(3 Pt 1):1109-1114.
10. Sin D.D., Leung R., Gan W.Q., Man S.P. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med 2007, 7:13.
11. Lomas D.A., Silverman E.K., Edwards L.D., Locantora N.W., Miller B.E., Horstman D.H., et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 2009, 34:95-102.
12. Krane M., Griese M. Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis. Eur Respir J 2003 Oct, 22(4):592-595.
13. Leth-Larsen R., Garred P., Jensenius H., Meschi J., Hartshorn K., Madsen J., et al. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 2005 Feb 1, 174(3):1532-1538.
14. Heidinger K., Konig I.R., Bohnert A., Kleinsteiber A., Hilgendorff A., Gortner L., et al. Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced. Immunogenetics 2005 Apr, 57(1-2):1-7.
15. Sorensen G.L., Hjelmborg J., Kyvik K.O., Fenger M., Høj A., Bendixen C., et al. Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 2006 May 1, 290(5):L1010-L1017.
16. Husby S., Herskind A.M., Jensenius J.C., Holmskov U. Heritability estimates for the constitutional levels of the collectins mannan-binding lectin and lung surfactant protein D. A study of unselected like-sexed mono- and dizygotic twins at the age of 6-9years. Immunology 2002 Jul, 106(3):389-394.
17. Pediatric Reference Ranges 1995, AACC Press, Washington DC. S.J. Soldin, J.M. Hicks (Eds.).
18. Nordin G., Martensson A., Swolin B., Sandberg S., Christensen N.J., Thorsteinsson V., et al. A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scand J Clin Lab Invest 2004, 64(4):385-398.
19. Solymar L., Aronsson P.H., Bake B., Bjure J. Nitrogen single breath test, flow-volume curves and spirometry in healthy children, 7-18years of age. Eur J Respir Dis 1980 Oct, 61(5):275-286.
20. Quanjer P.H., Tammeling G.j. Summary of recommendations. Standardized lung function testing. Report Working Party, European Community for Coal and Steel. Bull Eur Physiopathol Respir 1983, 19(S5):7-10.
21. Griese M., Essl R., Schmidt R., Rietschel E., Ratjen F., Ballmann M., et al. Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis. Am J Respir Crit Care Med 2004 Nov 1, 170(9):1000-1005.
22. Henderson N.G., Postle A.D., George D. Proteolysis of surfactant protein D (SP-D) in children with CF. J Cyst Fibros 2004, 3(Suppl 2):S23. Ref Type: Abstract.
23. Peckham D., Crouch S., Humphreys H., Lobo B., Tse A., Knox A.J. Effect of antibiotic treatment on inflammatory markers and lung function in cystic fibrosis patients with Pseudomonas cepacia. Thorax Aug. 1, 1994, 49(8):803-807.